Regarding promoted progression of gastric cancer by GTPBP4 regulation of P53 activity [12], we infer that aberrant GTPBP4 affects LUAD cell proliferation, apoptosis, and migration by disturbing the balance between ribosome biogenesis and P53 activity. The gene discussed is TP53; the disease is gastric cancer.